Say Li Kong

Say Li Kong

Auto-generated profile, based on publicly available information

Say Li Kong

Genome Institute of Singapore, Singapore 138672, Singapore

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2017 in Nature Genetics
Verified
Journal Article
Closed access
HLHuipeng Li
Huipeng Li
ECElise Courtois
Elise Courtois
DSDebarka Sengupta
Debarka Sengupta
YTYuliana Tan
Yuliana Tan
KCKok Hao Chen
Kok Hao Chen
SPShyam Prabhakar
Shyam Prabhakar

1 June 2007 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CLChin-Yo Lin
Chin-Yo Lin
VVVinsensius B Vega
Vinsensius B Vega
JTJane S Thomsen
Jane S Thomsen
TZTao Zhang
Tao Zhang
SKSay Li Kong
Say Li Kong
ELEdison T Liu
Edison T Liu
Using a chromatin immunoprecipitation-paired end diTag cloning and sequencing strategy, we mapped estrogen receptor α (ERα) binding sites in MCF-7 breast cancer cells. We identified 1,234 high confidence binding clusters of which 94% are projected to be bona fide ERα binding regions. Only 5% of the mapped estrogen receptor binding sites are located within 5 kb upstream of the transcriptional start sites of adjacent genes, regions containing the proximal promoters, whereas vast majority of the sites are mapped to intronic or distal locations (>5 kb from 5′ and 3′ ends of adjacent transcript), suggesting transcriptional regulatory mechanisms over significant physical distances. Of all the identified sites, 71% harbored putative full estrogen response elements (EREs), 25% bore ERE half sites, and only 4% had no recognizable ERE sequences. Genes in the vicinity of ERα binding sites were enriched for regulation by estradiol in MCF-7 cells, and their expression profiles in patient samples segregate ERα-positive from ERα-negative breast tumors. The expression dynamics of the genes adjacent to ERα binding sites suggest a direct induction of gene expression through binding to ERE-like sequences, whereas transcriptional repression by ERα appears to be through indirect mechanisms. Our analysis also indicates a number of candidate transcription factor binding sites adjacent to occupied EREs at frequencies much greater than by chance, including the previously reported FOXA1 sites, and demonstrate the potential involvement of one such putative adjacent factor, Sp1, in the global regulation of ERα target genes. Unexpectedly, we found that only 22%–24% of the bona fide human ERα binding sites were overlapping conserved regions in whole genome vertebrate alignments, which suggest limited conservation of functional binding sites. Taken together, this genome-scale analysis suggests complex but definable rules governing ERα binding and gene regulation. Estrogen receptors (ERs) play key roles in facilitating the transcriptional effects of hormone functions in target tissues. To obtain a genome-wide view of ERα binding sites, we applied chromatin immunoprecipitation coupled with a cloning and sequencing strategy using chromatin immunoprecipitation pair end-tagging technology to map ERα binding sites in MCF-7 human breast cancer cells. We identified 1,234 high quality ERα binding sites in the human genome and demonstrated that the binding sites are frequently adjacent to genes significantly associated with breast cancer disease status and outcome. The mapping results also revealed that ERα can influence gene expression across distances of up to 100 kilobases or more, that genes that are induced or repressed utilize sites in different regions relative to the transcript (suggesting different mechanisms of action), and that ERα binding sites are only modestly conserved in evolution. Using computational approaches, we identified potential interactions with other transcription factor binding sites adjacent to the ERα binding elements. Taken together, these findings suggest complex but definable rules governing ERα binding and gene regulation and provide a valuable dataset for mapping the precise control nodes for one of the most important nuclear hormone receptors in breast cancer biology.

12 August 2004 in Genome Biology
Verified
Journal Article
Open access
PDF file
CLChin-Yo Lin
Chin-Yo Lin
ASAnders Ström
Anders Ström
VVVinsensius Berlian Vega
Vinsensius Berlian Vega
SKSay Li Kong
Say Li Kong
AYAi Li Yeo
Ai Li Yeo
ELEdison T Liu
Edison T Liu
Background: Estrogens and their receptors are important in human development, physiology and disease. In this study, we utilized an integrated genome-wide molecular and computational approach to characterize the interaction between the activated estrogen receptor (ER) and the regulatory elements of candidate target genes. Results: Of around 19,000 genes surveyed in this study, we observed 137 ER-regulated genes in T-47D cells, of which only 89 were direct target genes. Meta-analysis of heterogeneous in vitro and in vivo datasets showed that the expression profiles in T-47D and MCF-7 cells are remarkably similar and overlap with genes differentially expressed between ER-positive and ER-negative tumors. Computational analysis revealed a significant enrichment of putative estrogen response elements (EREs) in the cis-regulatory regions of direct target genes. Chromatin immunoprecipitation confirmed ligand-dependent ER binding at the computationally predicted EREs in our highest ranked ER direct target genes, NRIP1, GREB1 and ABCA3. Wider examination of the cis-regulatory regions flanking the transcriptional start sites showed species conservation in mouse-human comparisons in only 6% of predicted EREs. Conclusions: Only a small core set of human genes, validated across experimental systems and closely associated with ER status in breast tumors, appear to be sufficient to induce ER effects in breast cancer cells. That cis-regulatory regions of these core ER target genes are poorly conserved suggests that different evolutionary mechanisms are operative at transcriptional control elements than at coding regions. These results predict that certain biological effects of estrogen signaling will differ between mouse and human to a larger extent than previously thought.

30 August 2011 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
SKSay Li Kong
Say Li Kong
Guoliang LiGuoliang Li
Guoliang Li
SLSiang Lin Loh
Siang Lin Loh
WSWing Kin Sung
Wing Kin Sung
ELEdison T Liu
Edison T Liu
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

21 December 2010 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
RJRoy Joseph
Roy Joseph
Yuriy L OrlovYuriy L Orlov
Yuriy L Orlov
MHMikael Huss
Mikael Huss
WSWenjie Sun
Wenjie Sun
SKSay Li Kong
Say Li Kong
ELEdison T Liu
Edison T Liu
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

29 June 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ICIgor Cima
Igor Cima
SKSay Li Kong
Say Li Kong
DSDebarka Sengupta
Debarka Sengupta
ITIain B. Tan
Iain B. Tan
WPWai Min Phyo
Wai Min Phyo
MTMin Han TAN
Min Han TAN
A population of cell clusters circulating in cancer patients consist of tumor-derived endothelial cells reflecting features of the tumor vasculature.